Signal Transducers and Activators of Transcription (STATs) are intracellular signaling proteins that are activated upon tyrosine phosphorylation and translocate from the cytosol to the nucleus where they bind to specific regions of DNA and exert transcriptional activity. STAT3 activation has been linked to transformation and tumor progression in several cancers, including squamous cell carcinoma of the head and neck (SCCHN). We have accumulated convincing evidence that constitutive STAT3 activation in SCCHN represents a critical survival pathway in SCCHN. We recently reported that activated STAT3 stimulated SCCHN growth independent of upstream growth factor receptors including EGFR. Further investigation demonstrated that activated STAT3 could be selectively targeted with a double stranded """"""""decoy"""""""" oligodeoxynucleotide (ODN) representing the high affinity serum inducible element (hSIE). Blocking activated STAT3 with a STAT3 decoy inhibited SCCHN proliferation and STAT3-mediated gene expression with no effect on the growth of normal mucosal epithelial cells. Therefore, the overall aim of this proposal is to develop a therapeutic strategy that targets activated STAT3, thereby inhibiting SCCHN progression. A transcription factor decoy approach will be optimized to achieve maximal anti-tumor effects, with the ultimate goal of generating a formulation for efficient delivery to human SCCHN cells. To accomplish the goals of this proposal, we will: 1) determine the prognostic significance of activated STAT3 in SCCHN patients; 2) optimize the structure and delivery of the STAT3 decoy to enhance stability and maximize cellular uptake; 3) examine the anti-tumor effects of the STAT3 decoy; and 4) determine the toxicity and pharmacokinetics of optimized STAT3 decoy in preclinical animal models.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA101840-03
Application #
7110247
Study Section
Drug Discovery and Molecular Pharmacology Study Section (DMP)
Program Officer
Arya, Suresh
Project Start
2004-08-01
Project End
2009-05-31
Budget Start
2006-07-19
Budget End
2007-05-31
Support Year
3
Fiscal Year
2006
Total Cost
$265,813
Indirect Cost
Name
University of Pittsburgh
Department
Otolaryngology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Yang, Wei; Cai, Quan; Lui, Vivian W Y et al. (2010) Quantitative proteomics analysis reveals molecular networks regulated by epidermal growth factor receptor level in head and neck cancer. J Proteome Res 9:3073-82
Leeman-Neill, Rebecca J; Cai, Quan; Joyce, Sonali C et al. (2010) Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors. Clin Cancer Res 16:2571-9
Wheeler, S E; Suzuki, S; Thomas, S M et al. (2010) Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation. Oncogene 29:5135-45
Leeman-Neill, Rebecca J; Wheeler, Sarah E; Singh, Shivendra V et al. (2009) Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3. Carcinogenesis 30:1848-56
Thomas, Sufi Mary; Grandis, Jennifer Rubin (2009) The current state of head and neck cancer gene therapy. Hum Gene Ther 20:1565-75
Li, Changyou; Zang, Yan; Sen, Malabika et al. (2009) Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death. Mol Cancer Ther 8:2211-20
Sen, Malabika; Tosca, Patricia J; Zwayer, Christa et al. (2009) Lack of toxicity of a STAT3 decoy oligonucleotide. Cancer Chemother Pharmacol 63:983-95
Seethala, Raja R; Gooding, William E; Handler, Phoebe N et al. (2008) Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes. Clin Cancer Res 14:1303-9
Boehm, Amanda L; Sen, Malabika; Seethala, Raja et al. (2008) Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neck. Mol Pharmacol 73:1632-42
Quesnelle, Kelly M; Boehm, Amanda L; Grandis, Jennifer R (2007) STAT-mediated EGFR signaling in cancer. J Cell Biochem 102:311-9

Showing the most recent 10 out of 14 publications